drugset / Trial / NCT03063476

The Effect of Acute Lysine Administration on α-aminoadipic Acid (Sub-study)

NCT03063476

Phase 1 Completed 2 enrolled Vanderbilt University Medical Center
NaSingle-groupOpen-labelBasic science

Summary

This sub-study aims to assess the effect and breakdown of lysine administration, specifically examining whether it leads to increased plasma 2-AAA in healthy humans.

Timeline

Start
2017-03-01
Primary completion
2017-05-18
Completion
2017-05-18

Drugs

EvaluationDrugModalityDoseRoute
Subject C-13 labeled Lysine Other / unclassified 5 g Oral
Background sodium chloride Unknown 10 ml Intravenous

Indications

No indication recorded.